{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:00:42Z","timestamp":1790420442511,"version":"4.1.0"},"reference-count":97,"publisher":"Ubiquity Press, Ltd.","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,16]]},"DOI":"10.5334\/tohm.351","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T11:20:14Z","timestamp":1594898414000},"source":"Crossref","is-referenced-by-count":15,"title":["Treatment of Secondary Chorea: A Review of the Current Literature"],"prefix":"10.5334","volume":"10","author":[{"given":"Erin","family":"Feinstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","reference":[{"key":"key20200716072007_B1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1080\/00325481.2015.1074031","article-title":"Identification and management of tardive dyskinesia: A case series and literature review","volume":"127","year":"2015","journal-title":"Postgrad. Med"},{"key":"key20200716072007_B2","first-page":"15","article-title":"Diagnosis and Treatment of Chorea Syndromes","year":"2015","journal-title":"Curr. Neurol. Neurosci. Rep"},{"key":"key20200716072007_B3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/B978-0-444-52014-2.00025-2","article-title":"Hyperkinetic movement disorders associated with HIV and other viral infections","volume":"100","year":"2011","journal-title":"Handbook of clinical neurology"},{"key":"key20200716072007_B4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0883073811414058","article-title":"Treatment of sydenham chorea with intravenous immunoglobulin","volume":"27","year":"2012","journal-title":"J. Child Neurol"},{"key":"key20200716072007_B5","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nm892","article-title":"Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea","volume":"9","year":"2003","journal-title":"Nat. Med"},{"key":"key20200716072007_B6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neulet.2012.06.073","article-title":"Infusion of Sydenham\u2019s chorea antibodies in striatum with up-regulated dopaminergic receptors: A pilot study to investigate the potential of SC antibodies to increase dopaminergic activity","volume":"523","year":"2012","journal-title":"Neurosci. Lett"},{"key":"key20200716072007_B7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/1756285610382063","article-title":"An update on the treatment of Sydenham\u2019s chorea: the evidence for established and evolving interventions","volume":"3","year":"2010","journal-title":"Ther. Adv. Neurol. Disord"},{"key":"key20200716072007_B8","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/0883073807302614","article-title":"Sydenham\u2019s chorea: a clinical follow-up of 65 patients","volume":"22","year":"2007","journal-title":"J. Child Neurol"},{"key":"key20200716072007_B9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1590\/S0004-282X2002000300006","article-title":"Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham\u2019s chorea: Clinical follow-up of 18 patients","volume":"60","year":"2002","journal-title":"Arq. Neuropsiquiatr"},{"key":"key20200716072007_B10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0887-8994(85)90037-2","article-title":"Valproic acid in the treatment of Sydenham chorea","volume":"1","year":"1985","journal-title":"Pediatr. Neurol"},{"key":"key20200716072007_B11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/08830738050200050601","article-title":"Treatment of Sydenham\u2019s Chorea with Intravenous Immunoglobulin, Plasma Exchange, or Prednisone","volume":"20","year":"2005","journal-title":"J. Child Neurol"},{"key":"key20200716072007_B12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pediatrneurol.2013.04.003","article-title":"Unusual trigeminal autonomic pain heralding hemichorea due to Zoster Sine herpete vasculopathy","volume":"49","year":"2013","journal-title":"Pediatr. Neurol"},{"key":"key20200716072007_B13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pediatrneurol.2012.11.010","article-title":"Chorea and Developmental Regression Associated With Human Herpes Virus-6 Encephalitis","volume":"48","year":"2013","journal-title":"Pediatr. Neurol"},{"key":"key20200716072007_B14","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3201\/eid1909.130804","article-title":"Chorea and tick-borne encephalitis, Poland","volume":"19","year":"2013","journal-title":"Emerg. Infect. Dis"},{"key":"key20200716072007_B15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.5334\/tohm.422","article-title":"Transient Generalized Chorea in Influenza A Encephalopathy","volume":"8","year":"2018","journal-title":"Tremor Other Hyperkinet. Mov. (N. Y)"},{"key":"key20200716072007_B16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.tmaid.2011.10.002","article-title":"West Nile Virus (WNV) infection presenting as acute chorea","volume":"10","year":"2012","journal-title":"Travel Med. Infect. Dis"},{"key":"key20200716072007_B17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1179\/146532810X12858955921438","article-title":"Childhood chorea-encephalopathy associated with recent parvovirus B19 infection in two Jamaican children","volume":"30","year":"2010","journal-title":"Ann. Trop. Paediatr"},{"key":"key20200716072007_B18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4103\/0028-3886.53277","article-title":"Chorea as the presentating feature of neurosyphilis","volume":"57","year":"2009","journal-title":"Neurol. India"},{"key":"key20200716072007_B19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1590\/S0004-27492008000500020","article-title":"Vitreitis and movement disorder associated with neurosyphilis and human immunodeficiency virus (HIV) infection: case report","volume":"71","year":"2008","journal-title":"Arq. Bras. Oftalmol"},{"key":"key20200716072007_B20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/003693309303800309","article-title":"A Patient with Neurosyphilis Presenting as Chorea","volume":"38","year":"1993","journal-title":"Scott. Med. J"},{"key":"key20200716072007_B21","first-page":"89","article-title":"Resolution of choreic movements associated with HIV encephalitis with anti-retroviral therapy","volume":"162","year":"2006","journal-title":"Rev. Neurol. (Paris)"},{"key":"key20200716072007_B22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/mds.870040308","article-title":"Hemichorea-hemiballismus associated with acquired immune deficiency syndrome and cerebral toxoplasmosis","volume":"4","year":"1989","journal-title":"Mov. Disord"},{"key":"key20200716072007_B23","first-page":"332","article-title":"Chorea in patients with AIDS","volume":"100","year":"1999","journal-title":"Acta Neurol. Scand"},{"key":"key20200716072007_B24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/mds.870110414","article-title":"Choreoathetosis in acquired immune deficiency syndrome patients with cerebral toxoplasmosis","volume":"11","year":"1996","journal-title":"Mov. Disord"},{"key":"key20200716072007_B25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ana.410190303","article-title":"Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients","volume":"19","year":"1986","journal-title":"Ann. Neurol"},{"key":"key20200716072007_B26","first-page":"75","article-title":"Hemichorea in a patient with HIV-associated central nervous system histoplasmosis","volume":"27","year":"2014","journal-title":"Int. J. STD AIDS"},{"key":"key20200716072007_B27","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0735-6757(91)90125-4","article-title":"Cocaine and chorea","volume":"9","year":"1991","journal-title":"Am. J. Emerg. Med"},{"key":"key20200716072007_B28","article-title":"Cracking the Crack Dance: A Case Report on Cocaine-induced Choreoathetosis","volume":"9","year":"2017","journal-title":"Cureus"},{"key":"key20200716072007_B29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.pediatrneurol.2012.05.013","article-title":"Acute, Sustained Chorea in Children After Supratherapeutic Dosing of Amphetamine-Derived Medications","volume":"47","year":"2012","journal-title":"Pediatr. Neurol"},{"key":"key20200716072007_B30","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/mds.20081","article-title":"Amphetamine-induced chorea in attention deficit-hyperactivity disorder","volume":"19","year":"2004","journal-title":"Mov. Disord"},{"key":"key20200716072007_B31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1742-6723.2005.00735.x","article-title":"Amphetamine-induced movement disorder","volume":"17","year":"2005","journal-title":"Emerg. Med. Australas"},{"key":"key20200716072007_B32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0735-6757(88)90050-2","article-title":"Choreoathetoid Disorder Associated with Amphetamine-like Drugs","volume":"6","year":"1988","journal-title":"Am. J. Emerg. Med"},{"key":"key20200716072007_B33","doi-asserted-by":"crossref","first-page":"986","DOI":"10.7326\/0003-4819-121-12-199412150-00019","article-title":"Methamphetamine-induced choreoathetosis and rhabdomyolysis","volume":"121","year":"1994","journal-title":"Ann. Intern. Med"},{"key":"key20200716072007_B34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5414\/CN107559","article-title":"Sympathomimetic syndrome, choreoathetosis, and acute kidney injury following \u201cbath salts\u201d injection","volume":"81","year":"2014","journal-title":"Clin. Nephrol"},{"key":"key20200716072007_B35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.amjopharm.2010.08.006","article-title":"Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders","volume":"8","year":"2010","journal-title":"Am. J. Geriatr. Pharmacother"},{"key":"key20200716072007_B36","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1212\/WNL.0000000000003960","article-title":"Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study","volume":"88","year":"2017","journal-title":"Neurology"},{"key":"key20200716072007_B37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S2215-0366(17)30236-5","article-title":"Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"4","year":"2017","journal-title":"The lancet. Psychiatry"},{"key":"key20200716072007_B38","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1176\/appi.ajp.2017.16091037","article-title":"KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia","volume":"174","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"key20200716072007_B39","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4088\/JCP.v69n0405","article-title":"Effects of levetiracetam on tardive dyskinesia: a randomized, double-blind, placebo-controlled study","volume":"69","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"key20200716072007_B40","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1212\/WNL.50.5.1323","article-title":"Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson\u2019s disease","volume":"50","year":"1998","journal-title":"Neurology"},{"key":"key20200716072007_B41","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.parkreldis.2005.05.008","article-title":"Amantadine reduces the duration of levodopa-induced dyskinesia: a randomized, double-blind, placebo-controlled study","volume":"11","year":"2005","journal-title":"Parkinsonism Relat. Disord"},{"key":"key20200716072007_B42","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/mds.1112","article-title":"Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study","volume":"16","year":"2001","journal-title":"Mov. Disord"},{"key":"key20200716072007_B43","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/mds.23034","article-title":"Long-term antidyskinetic efficacy of amantadine in Parkinson\u2019s disease","volume":"25","year":"2010","journal-title":"Mov. Disord"},{"key":"key20200716072007_B44","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1212\/WNL.0000000000000050","article-title":"Withdrawing amantadine in dyskinetic patients with Parkinson disease: The AMANDYSK trial","volume":"82","year":"2014","journal-title":"Neurology"},{"key":"key20200716072007_B45","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa060281","article-title":"A Randomized Trial of Deep-Brain Stimulation for Parkinson\u2019s Disease","volume":"355","year":"2006","journal-title":"N. Engl. J. Med"},{"key":"key20200716072007_B46","first-page":"E3","article-title":"Comparison of pallidal and subthalamic deep brain stimulation for the treatment of levodopa-induced dyskinesias","volume":"17","year":"2004","journal-title":"Neurosurgical focus"},{"key":"key20200716072007_B47","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/mds.1046","article-title":"Does stimulation of the GPi control dyskinesia by activating inhibitory axons?","volume":"16","year":"2001","journal-title":"Mov. Disord"},{"key":"key20200716072007_B48","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/mds.25164","article-title":"Parkinson\u2019s disease medication use and costs following deep brain stimulation","volume":"27","year":"2012","journal-title":"Mov. Disord"},{"key":"key20200716072007_B49","first-page":"549","article-title":"Putaminal petechial haemorrhage as the cause of non-ketotic hyperglycaemic chorea: A neuropathological case correlated with MRI findings 7","volume":"78","year":"2007","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"key20200716072007_B50","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/syn.20863","article-title":"Impact of STZ-induced hyperglycemia and insulin-induced hypoglycemia in plasma amino acids and cortical synaptosomal neurotransmitters","volume":"65","year":"2011","journal-title":"Synapse"},{"key":"key20200716072007_B51","first-page":"863","article-title":"Hemichorea-hemiballism: An explanation for MR signal changes","volume":"19","year":"1998","journal-title":"Am. J. Neuroradiol"},{"key":"key20200716072007_B52","first-page":"PL01","article-title":"Case Report of Chorea Associated with Hyperthyroidism","volume":"10","year":"2016","journal-title":"J. Clin. DIAGNOSTIC Res"},{"key":"key20200716072007_B53","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2169\/internalmedicine.31.1144","article-title":"Persistent hemichorea associated with thyrotoxicosis","volume":"31","year":"1992","journal-title":"Intern. Med"},{"key":"key20200716072007_B54","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/mds.20603","article-title":"Chorea associated with thyroxine replacement therapy","volume":"20","year":"2005","journal-title":"Mov. Disord"},{"key":"key20200716072007_B55","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/mds.10477","article-title":"Efficacy of propranolol in hyperthyroid-induced chorea: A case report","volume":"18","year":"2003","journal-title":"Mov. Disord"},{"key":"key20200716072007_B56","first-page":"2012","article-title":"Chorea gravidarum: a rarity in West still haunts pregnant women in the East","year":"2013","journal-title":"BMJ Case Rep"},{"key":"key20200716072007_B57","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.parkreldis.2011.12.013","article-title":"Pregnancy in patients with Sydenham\u2019s chorea","volume":"18","year":"2012","journal-title":"Park. Relat. Disord"},{"key":"key20200716072007_B58","article-title":"Identifying the aetiology of sudden acute abnormal involuntary movements in a primigravid","volume":"11","year":"2018","journal-title":"BMJ Case Rep"},{"key":"key20200716072007_B59","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1212\/WNL.33.6.750","article-title":"Chronic dopaminergic sensitivity after Sydenham\u2019s chorea","volume":"33","year":"1983","journal-title":"Neurology"},{"key":"key20200716072007_B60","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4103\/0253-7613.153440","article-title":"Oral contraceptive pills induced hemichorea in an adolescent female with polycystic ovarian disease","volume":"47","year":"2015","journal-title":"Indian J. Pharmacol"},{"key":"key20200716072007_B61","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.parkreldis.2018.09.006","article-title":"Simultaneous acute presentation of generalized chorea and subacute combined degeneration secondary to vitamin B12 deficiency","volume":"55","year":"2018","journal-title":"Parkinsonism Relat. Disord"},{"key":"key20200716072007_B62","doi-asserted-by":"crossref","unstructured":"Battista J, Walker R. Chorea: Classification, Differential, Diagnosis, and Treatment. Scientific American Neurology; 2015. Available at: https:\/\/www.deckerip.com\/products\/scientific-american-neurology\/.","DOI":"10.2310\/NEURO.6356"},{"key":"key20200716072007_B63","first-page":"1","article-title":"Current treatment of antiphospholipid syndrome: lights and shadows","volume":"11","year":"2015","journal-title":"Nat. Rev. Rheumatol"},{"key":"key20200716072007_B64","first-page":"1","article-title":"Antiphospholipid-related chorea","volume":"3","year":"2012","journal-title":"Front. Neurolgoy"},{"key":"key20200716072007_B65","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1212\/WNL.0b013e3182886991","article-title":"Autoimmune chorea in adults","volume":"80","year":"2013","journal-title":"Neurology"},{"key":"key20200716072007_B66","first-page":"23","article-title":"Chorea and antiphospholipid antibodies: Treatment with methotrexate","year":"2011","journal-title":"Neurology"},{"key":"key20200716072007_B67","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3109\/14397595.2015.1134035","article-title":"Mycophenolate mofetil therapy for two cases of antiphospholipid antibody-associated chorea","volume":"28","year":"2018","journal-title":"Mod. Rheumatol"},{"key":"key20200716072007_B68","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/s10067-007-0627-9","article-title":"Efficacy of intravenous immunoglobulin treatment in lupus erythematosus chorea","volume":"26","year":"2007","journal-title":"Clin. Rheumatol"},{"key":"key20200716072007_B69","article-title":"Isolated Chorea Associated with LGI1 Antibody","year":"2014","journal-title":"Tremor Other Hyperkinet. Mov. (N. Y)"},{"key":"key20200716072007_B70","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/jnnp.74.9.1221","article-title":"Dietary treatment of gluten ataxia","volume":"74","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"key20200716072007_B71","article-title":"Further Evidence for Celiac Disease-associated Chorea?","year":"2011","journal-title":"Tremor and Other Hyperkinetic Movements"},{"key":"key20200716072007_B72","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/mds.10691","article-title":"Choreic syndrome and coeliac disease: a hitherto unrecognised association","volume":"19","year":"2004","journal-title":"Mov. Disord"},{"key":"key20200716072007_B73","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.parkreldis.2018.06.008","article-title":"Movement disorders in non-encephalopathic Hashimoto\u2019s thyroiditis","volume":"55","year":"2018","journal-title":"Parkinsonism and Related Disorders"},{"key":"key20200716072007_B74","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/mds.10230","article-title":"Choreic syndrome due to Hashimoto\u2019s encephalopathy","volume":"17","year":"2002","journal-title":"Mov. Disord"},{"key":"key20200716072007_B75","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11940-018-0529-y","article-title":"An Update on the Treatment of Chorea","volume":"20","year":"2018","journal-title":"Curr. Treat. Options Neurol"},{"key":"key20200716072007_B76","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3324\/haematol.2011.043018","article-title":"A pilot trial of deferiprone for neurodegeneration with brain iron accumulation","volume":"96","year":"2011","journal-title":"Haematologica"},{"key":"key20200716072007_B77","first-page":"99","article-title":"Neurodegeneration with brain iron accumulation: Update on pathogenic mechanisms","year":"2014","journal-title":"Frontiers in Pharmacology"},{"key":"key20200716072007_B78","first-page":"905","article-title":"Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation","volume":"23","year":"2008","journal-title":"Mov. Disord"},{"key":"key20200716072007_B79","year":"1993","journal-title":"Aceruloplasminemia. GeneReviews(\u00ae)"},{"key":"key20200716072007_B80","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ana.410410318","article-title":"Use of desferrioxamine in the treatment of aceruloplasminemia","volume":"41","year":"1997","journal-title":"Ann. Neurol"},{"key":"key20200716072007_B81","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.2169\/internalmedicine.52.0102","article-title":"Effectiveness of oral iron chelator treatment with deferasirox in an aceruloplasminemia patient with a novel ceruloplasmin gene mutation","volume":"52","year":"2013","journal-title":"Intern. Med"},{"key":"key20200716072007_B82","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/B978-0-12-410502-7.00007-7","article-title":"Aceruloplasminemia","volume":"110","year":"2013","journal-title":"International review of neurobiology"},{"key":"key20200716072007_B83","doi-asserted-by":"crossref","first-page":"355","DOI":"10.5334\/tohm.317","article-title":"Neuroferritinopathy: Pathophysiology, Presentation, Differential Diagnoses and Management","volume":"6","year":"2016","journal-title":"Tremor Other Hyperkinet. Mov. (N. Y)"},{"key":"key20200716072007_B84","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/jnen\/64.4.280","article-title":"Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights","volume":"64","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"key20200716072007_B85","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng572","article-title":"A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome","volume":"28","year":"2001","journal-title":"Nat. Genet"},{"key":"key20200716072007_B86","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10072-016-2756-x","article-title":"Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment","volume":"38","year":"2017","journal-title":"Neurol. Sci"},{"key":"key20200716072007_B87","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jnnp.2007.120568","article-title":"Aceruloplasminaemia with progressive atrophy without brain iron overload: treatment with oral chelation","volume":"79","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"key20200716072007_B88","first-page":"110","article-title":"Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation","volume":"130","year":"2007","journal-title":"Brain"},{"key":"key20200716072007_B89","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.parkreldis.2012.06.021","article-title":"Neuroferritinopathy","volume":"18","year":"2012","journal-title":"Parkinsonism Relat. Disord"},{"key":"key20200716072007_B90","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1002\/mds.23299","article-title":"Dramatic response of facial stereotype\/tic to tetrabenazine in the first reported cases of neuroferritinopathy in the United States","volume":"25","year":"2010","journal-title":"Mov. Disord"},{"key":"key20200716072007_B91","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00415-014-7240-z","article-title":"GLUT1 deficiency syndrome into adulthood: A follow-up study","volume":"261","year":"2014","journal-title":"J. Neurol"},{"key":"key20200716072007_B92","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/ng.1008","article-title":"Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia","volume":"43","year":"2011","journal-title":"Nat. Genet"},{"key":"key20200716072007_B93","first-page":"387","article-title":"Classification of paroxysmal dyskinesias and ataxias","volume":"89","year":"2002","journal-title":"Adv. Neurol"},{"key":"key20200716072007_B94","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1212\/01.WNL.0000147298.05983.50","article-title":"Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: New diagnostic criteria","volume":"63","year":"2004","journal-title":"Neurology"},{"key":"key20200716072007_B95","first-page":"19","article-title":"Clinical features of patients with paroxysmal kinesigenic dyskinesia, mutation screening of PRRT2 and the effects of morning draughts of oxcarbazepine","year":"2019","journal-title":"BMC Pediatr"},{"key":"key20200716072007_B96","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ncl.2014.09.014","article-title":"Paroxysmal movement disorders","volume":"33","year":"2015","journal-title":"Neurol. Clin"},{"key":"key20200716072007_B97","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1474-4422(14)70190-5","article-title":"Wilson\u2019s disease and other neurological copper disorders","volume":"14","year":"2015","journal-title":"Lancet"}],"container-title":["Tremor and Other Hyperkinetic Movements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/doi.org\/10.5334\/tohm.351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T09:23:41Z","timestamp":1657531421000},"score":1,"resource":{"primary":{"URL":"https:\/\/tremorjournal.org\/articles\/10.5334\/tohm.351\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7,16]]}},"alternative-id":["10.5334\/tohm.351"],"URL":"https:\/\/doi.org\/10.5334\/tohm.351","relation":{},"ISSN":["2160-8288"],"issn-type":[{"value":"2160-8288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"article-number":"22"}}